Skip to main content
See every side of every news story
Published • loading... • Updated

[Opinion] Veteran Needham analyst sees 44% upside in tumbling health stock

Summary by BizToc
GE HealthCare Technologies (GEHC) has had a rough year, and investors have been asking whether the selling is over, or whether more losses lie ahead. Needham & Company gave investors their opinion on Sept. 22. The firm started coverage of GEHC with a Buy rating and a $93 price target, pointing to…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizToc broke the news on Saturday, September 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal